JR-171

· JCR Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JR-171, covering 2025-03-19 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I) [Phase 1, Phase 2]